Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
US-2025129046-A1 · Apr 24, 2025 · US
This page is not indexed by search engines while we improve data quality.
Esposito Mark patents
Esposito Mark is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Esposito Mark |
| Total patents | 7 |
| First publication | May 27, 2021 |
| Latest publication | Apr 24, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
US-12162855-B2 · Dec 10, 2024 · US
Substituted heterocycles as aldehyde dehydrogenase inhibitors
US-2024343709-A1 · Oct 17, 2024 · US
Substituted heterocycles as aldehyde dehydrogenase inhibitors
US-12054475-B2 · Aug 6, 2024 · US
Heterocyclic compounds and uses thereof
US-2024132469-A1 · Apr 25, 2024 · US
Heterocyclic compounds and uses thereof
US-2023128402-A1 · Apr 27, 2023 · US
Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
US-2021155602-A1 · May 27, 2021 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Princeton | 7 |
| Kayothera Inc | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D401/12 | 7 |
| A61P35/00 | 7 |
| C07D417/12 | 4 |
| C07D413/12 | 4 |
| C07D471/04 | 4 |